CClinicalTrials.gg
Not yet recruitingNCT07272954Updated Sep 11, 2026

Effects of Ultrasound-Guided Stellate Ganglion Block and Transcutaneous Auricular Vagus Nerve Stimulation on Sleep Quality After Radical Mastectomy for Breast Cancer

An interventional study of SGB and taVNS in Sleep Disorder (Disorder), sponsored by Affiliated Hospital of Jiaxing University. Not yet recruiting. Open to female participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-09-11.

Sponsored by Affiliated Hospital of Jiaxing University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
136
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
Female
01

Study summary

This study aims to design a prospective, randomized, controlled, dual-center, non-inferiority trial to compare the effects of ultrasound-guided sympathetic ganglion block (SGB) and transcutaneous auricular vagus nerve stimulation (taVNS) on sleep quality following radical mastectomy for breast cancer. The objective is to explore whether non-invasive neuromodulation for sleep is non-inferior to invasive neuromodulation. Participants will be randomly assigned to receive either SGB or taVNS treatment. Sleep quality will be assessed using an actigraphy device and sleep scales within four days post-surgery, and the incidence of sleep disturbances will be followed up within 30 days post-surgery.

02

Conditions studied

  • Sleep Disorder (Disorder)

Browse trials for

Keywords

  • taVNS
03

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • aged 18-80 years who underwent radical surgery for breast cancer
  • ASA I-III

Exclusion criteria

Exclusion Criteria:

  • 1. Patients with coagulation dysfunction;
  • Patients with suspected regional infection leading to severe nerve damage in the affected limb;
  • Patients with congenital heart disease, coronary artery disease, myocardial infarction, severe cardiac conduction block, or those with implanted cardiac pacemakers;
  • Patients with severe neurological disorders such as cerebral infarction, cerebral hemorrhage, or stroke;
  • Patients with pain, lesions, infections, or unresolved external ear trauma in the area near the external ear;
  • Patients with severe mental illness or a history of substance abuse related to analgesics or psychiatric medications;
  • Patients with allergies to local anesthetics such as lidocaine or ropivacaine, as well as to general anesthetics;
  • Patients and their families who refuse surgical anesthesia and those unable to complete the survey questionnaire.
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
136 participants (estimated)

Study arms

  • Active comparator
    Stellate Ganglion Block(SGB)

    Before the induction of anesthesia in the operating room, a skilled anesthesiologist performed a SGB under sterile conditions using real-time ultrasound in a blind grouping manner.

    Procedure: SGB

  • Experimental
    transcutaneous vagus nerve stimulation(taVNS)

    Three stimulations of transcutaneous auricular vagus nerve stimulation (taVNS) were administered to the patients

    Device: taVNS

Interventions

  • ProcedureSGB

    Before the induction of anesthesia in the operating room, a skilled anesthesiologist performed a SGB under sterile conditions using real-time ultrasound in a blind grouping manner. The patient was positioned supine with the neck slightly rotated to the left. A linear probe (6-13 MHz) was placed on the neck to clearly visualize the carotid artery, internal jugular vein, vertebral artery, vagus nerve, thyroid gland, esophagus, scalene muscles, and the anterior scalene muscle at the C6 level. Subsequently, a 48mm, 20-gauge needle was inserted in a "plane" direction into the prevertebral fascia of the anterior scalene muscle. After the needle tip penetrated the prevertebral fascia and negative pressure aspiration was confirmed, 3ml of 0.5% ropivacaine was injected, and the diffusion of the local anesthetic was observed under ultrasound guidance.

  • DevicetaVNS

    Three stimulations of transcutaneous auricular vagus nerve stimulation (taVNS) were administered to the patients: ① According to the manufacturer's recommendations and previous studies \[32\], the initial adjustment required electrical stimulation to penetrate the skin barrier. The first intervention was conducted one day prior to the surgery, with an initial electrical stimulation frequency set at 30 Hz and a pulse width of 300 μs. The frequency and pulse width were adjusted based on the individual patient's sensations until the maximum tolerable current stimulation was reached without discomfort, lasting for 30 minutes; ② The second intervention occurred immediately after the patient was connected to the monitoring equipment in the operating room, once their vital signs were confirmed to be within normal ranges. The same stimulation frequency as the first intervention was applied for 30 minutes; ③ The third intervention was administered in the recovery room after the patient's surgery

05

What researchers measure

Primary outcomes

  1. Total Sleep Time on the First Night Post-Surgery

    Total Sleep Time Monitored by Actigraphy on the First Night Post-Surgery

    Time frame: the First Night Post-Surgery

Secondary outcomes

  1. Total sleep time from the second to the fourth night post-surgery

    Total sleep time each night from the second to the fourth night post-surgery by Actigraphy

    Time frame: the second to the fourth night post-surgery

  2. Assessment of sleep quality during the first four nights postoperatively

    Assessment of sleep quality using the Richards-Campbell Sleep Questionnaire(RCSQ) sleep questionnaire during the first four nights postoperatively. The total score is 150 points, with the minimum score being 0 points. A higher score indicates better postoperative sleep quality.

    Time frame: during the first four nights postoperatively

  3. sleep quality and the incidence of sleep disturbances on the 30th postoperative day

    On the 30th postoperative day, the Pittsburgh Sleep Quality Index (PSQI) will be used to assess subjective sleep quality and the incidence of sleep disturbances.The score ranges from 0 to 21 points, with higher scores indicating worse postoperative sleep quality.A score greater than 7 indicates the presence of sleep disturbance.

    Time frame: On the 30th postoperative day

  4. The incidence of all complications and mortality within 72 hours postoperatively

    The incidence of all complications and mortality within 72 hours postoperatively

    Time frame: within 72 hours postoperatively

  5. Quality of Recovery score at 24 hours postoperatively (QoR-15).

    Quality of Recovery score at 24 hours postoperatively (QoR-15). The score ranges from 0 to 150 points, with higher scores indicating better postoperative recovery quality.

    Time frame: at 24 hours postoperatively

06

Study locations

No study locations are listed for this record.

07

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07272954
Lead sponsor
Affiliated Hospital of Jiaxing University
Responsible party
Qing-he Zhou (PHD, Affiliated Hospital of Jiaxing University) — Principal investigator
First posted
Dec 9, 2025
Start date
Dec 1, 2026 (estimated)
Primary completion
Dec 1, 2029 (estimated)
Completion
Dec 1, 2029 (estimated)
Last update
Sep 11, 2026

Study contacts

Mingzi An
Contact
anmingzizi@163.com
+8618035193080

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion